The oncogenic HSP90, which optimizes several MYC metabolic programs, is indispensable to fulfill biomass, energetic, and secretory demands of B-cell lymphomas and, specifically, to support the metabolic process driven by MYC [121]. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.